Point72 Hong Kong LTD Ionis Pharmaceuticals Inc Transaction History

Point72 Hong Kong LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $868,450 - $1.03 Million	20,015 New	20,015 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $136,659 - $181,988	3,740 New	3,740 $165,000
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $76,960 - $104,361	-2,427 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $37,021 - $45,892	1,239 Added 104.29%	2,427 $90,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $30,424 - $41,698	1,188 New	1,188 $36,000
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $37,058 - $48,290	-791 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $130,540 - $198,949	-3,138 Reduced 79.87%	791 $37,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $211,576 - $256,445	3,929 New	3,929 $237,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $24,898 - $34,542	-401 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $21,220 - $32,549	401 New	401 $33,000
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $101,243 - $126,648	-2,498 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $79,167 - $98,869	1,796 Added 255.84%	2,498 $110,000
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $35,310 - $45,201	702	702 $35,000

407

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.53B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.